Ari Maizel Axsome Therapeutics, Inc. (AXSM) insider trading activity

AXSM Quotes by TradingView

Ari Maizel is Chief Commercial Officer of Axsome Therapeutics, Inc.. Currently has a direct ownership of 0 shares of AXSM, which is worth approximately $0. The most recent transaction as insider was on Jan 21, 2026, when has been sold 7,500 shares (Common Stock) at a price of $184.44 per share, resulting in proceeds of $1,383,300. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
n/a 3M change
n/a 12M change
Total Value Held $0

Ari Maizel Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 21 2026
SELL
Open market or private sale
$1,383,300 $184.44 p/Share
7,500 Reduced 100.0%
0 Common Stock
Jan 21 2026
BUY
Exercise of conversion of derivative security
$530,475 $70.73 p/Share
7,500 Added 50.0%
7,500 Common Stock
AM

Ari Maizel

Chief Commercial Officer
New York, NY

Track Institutional and Insider Activities on AXSM

Follow Axsome Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AXSM shares.

Notify only if

Insider Trading

Get notified when an Axsome Therapeutics, Inc. insider buys or sells AXSM shares.

Notify only if

News

Receive news related to Axsome Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AXSM